Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;27(8):2097-2106.
doi: 10.3201/eid2708.203740.

Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011-2016

Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011-2016

Amrei Krings et al. Emerg Infect Dis. 2021 Aug.

Abstract

Toxoplasmosis is a zoonotic infection contracted through Toxoplasma gondii-contaminated food, soil, or water. Seroprevalence in Germany is high, but estimates of disease incidence are scarce. We investigated incidences for various toxoplasmosis manifestations using anonymized healthcare claims data from Germany for 2011-2016. Patients with a toxoplasmosis diagnosis during the annual observational period were considered incident. The estimated incidence was adjusted to the general population age/sex distribution. We estimated an annual average of 8,047 toxoplasmosis patients in Germany. The average incidence of non-pregnancy-associated toxoplasmosis patients was 9.6/100,000 population. The incidence was highest in 2011, at 10.6 (95% CI 9.4-12.6)/100,000 population, and lowest in 2016, at 8.0 (95% CI 7.0-9.4)/100,000 population. The average incidence of toxoplasmosis during pregnancy was 40.3/100,000 pregnancies. We demonstrate a substantial toxoplasmosis disease burden in Germany. Public health and food safety authorities should implement toxoplasmosis-specific prevention programs.

Keywords: Germany; Toxoplasma gondii; food safety; healthcare claims data; incidence; parasites; toxoplasmosis; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Visualization of different inclusion and exclusion definitions for study of toxoplasmosis incidence based on healthcare claims data, Germany, 2011–2016.
Figure 2
Figure 2
Visualization of different inclusion and exclusion definitions of recurring medical claims and identification of underlying conditions for study of toxoplasmosis incidence based on healthcare claims data, Germany, 2011–2016.
Figure 3
Figure 3
Toxoplasmosis disease incidence by federal state in Germany, 2016. Error bars indicate 95% CIs. No estimates were available for Bremen, Saarland, and Thüringen. NA, not available.

Similar articles

Cited by

References

    1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–76. 10.1016/S0140-6736(04)16412-X - DOI - PubMed
    1. Robert Koch-Institut. RKI guide: toxoplasmosis. 2018. [cited 2021 Jun 21]. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxo...
    1. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001;56:296–305. 10.1097/00006254-200105000-00025 - DOI - PubMed
    1. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385–94. 10.1016/j.ijpara.2009.04.003 - DOI - PubMed
    1. Hofhuis A, van Pelt W, van Duynhoven YT, Nijhuis CD, Mollema L, van der Klis FR, et al. Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007. Epidemiol Infect. 2011;139:530–8. 10.1017/S0950268810001044 - DOI - PubMed

Publication types

Substances